MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    The effect of dopaminergic medication on force fluctuation in Parkinson’s disease

    B. Afsharipour, M. Schindle, F. Roy, F. Ba, M. Gorassini, T. Sankar (Edmonton, Canada)

    Objective: To quantify and compare muscle force variability during isometric dorsiflexion in male patients with Parkinson's Disease (PD), in the ON- versus OFF-medication state. Background:…
  • 2023 International Congress

    Sexual health and sleep quality in women living with Parkinson’s disease: are we neglecting that?

    KCN. Nobrega, TSM. Martins, GFS. Santos, MEP. Piemonte (Sao Paulo, Brazil)

    Objective: To investigate the relationship between sexual health and sleep quality in PD. Background: Sexual dysfunction (SD) is a common yet under-reported, non-motor symptom (NMS)…
  • 2023 International Congress

    Distinct characteristics of gut microbiome in patients with Parkinson’s disease according to the presence of premotor REM sleep behavior disorders

    S. Jo, JY. Lee, JW. Bae, SJ. Chung (Seoul, Republic of Korea)

    Objective: We aimed to investigate whether the composition and function of gut microbiome obtained from shotgun metagenomic sequencing are different between Parkinson’s disease (PD) patients…
  • 2023 International Congress

    modulation of sodium potassium ATPase activity by norepinepherine and serotonin to find an effective cure of parkinson’s disease by introducing the novel concept of insilico drug repurposing

    S. Sinha (Prayagraj, India)

    Objective: Parkinson's disease can cause neuropsychiatric disturbances which can range from mild to severe. This includes disorders of speech, cognition, mood, behaviour, and thought. In addition to…
  • 2023 International Congress

    Exercise and levodopa metabolism in Parkinson disease

    M. Figura, J. Giebułtowicz, A. Mrozowicz, S. Szlufik, D. Koziorowski (Warsaw, Poland)

    Objective: The aim of our paper was to assess if standard physical exercise may change pharmacokinetics of levodopa/benserazide in patients with and without prior exposure…
  • 2023 International Congress

    Tongue fasciculations and numbness: A case of calcifying pseudoneoplasm

    S. Hudaib, N. Stubbs, L. Simon, V. Blake, E. Nduom, C. Branson (Atlanta, USA)

    Objective: To describe a 61-year-old female who presents with abnormal tongue movement found to have right frontoparietal calcifying pseudoneoplasm of the neuraxis (CAPNON). Background: CAPNON…
  • 2023 International Congress

    Apathy, white-matter microstructure, and effort-based decision making in Parkinson’s Disease

    N. Vanegas-Arroyave, C. Leheron, Z. He, S. Lee, E. Huey, Y. Gazes (Houston, USA)

    Objective: To investigate the influence of reward and effort on behavior in PD patients with and without apathy, using a drift-diffusion model to analyze neuroimage…
  • 2023 International Congress

    Multimodal imaging analysis of autosomal recessive Parkinson’s disease.

    B. Soydas-Turan, G. Yalcin-Cakmakli, E. Yetim, B. Volkan-Salanci, E. Lay-Ergun, K. Karli-Oguz, B. Elibol (Ankara, Turkey)

    Objective: To explore whether autosomal recessive forms of monogenic PD (mPD) might lead to cortical and white matter (WM) abnormalities in addition to dopaminergic denervation.…
  • 2023 International Congress

    Novel CACNA1A splice site variant associated with cerebellar ataxia and mild cognitive impairment; case report of Czech family.

    A. Afifi, M. Nevrly, Z. Musova, P. Hedvicakova, K. Mensikova, P. Kanovsky (Olomouc, Czech Republic)

    Objective: To describe a case of two related individuals with cerebellar ataxia with a novel variant in the calcium voltage-gated channel subunit alpha1-A (CACNA1A) gene.…
  • 2023 International Congress

    Prodromal stage early biomarkers in Parkinson’s disease and parkinsonism in Uzbek nationality

    DT. Akramova, GS. Rakhimbaeva (Tashkent, Uzbekistan)

    Objective: Evaluation of prodromal stage biomarkers in Parkinson's disease and their role in disease progression Background: From a pathophysiological point of view, PD is characterized…
  • « Previous Page
  • 1
  • …
  • 43
  • 44
  • 45
  • 46
  • 47
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
        • Help & Support
        • About Us
        • Cookies & Privacy
        • Wiley Job Network
        • Terms & Conditions
        • Advertisers & Agents
        Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
        Wiley